COST-EFFECTIVENESS ANALYSIS OF TOFACITINIB IN THE TREATMENT OF ULCERATIVE COLITIS IN THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTHCARE SYSTEM

被引：0
|
作者：
Holanda, P. [1 ]
Salgado De Santana, C. [2 ]
Senna, T. [1 ]
Carmo, L. [1 ]
Alexandre, R. F. [1 ]
机构：
[1] Pfizer Inc, Sao Paulo, Brazil
[2] Pfizer Inc, Santos, SP, Brazil
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI11
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [1] BUDGET IMPACT ANALYSIS OF TOFACITINIB IN THE TREATMENT OF ULCERATIVE COLITIS IN THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTHCARE SYSTEM
    Holanda, P.
    Salgado De Santana, C.
    Senna, T.
    Carmo, L.
    Alexandre, R. F.
    VALUE IN HEALTH, 2021, 24 : S96 - S97
  • [2] COST-EFFECTIVENESS ANALYSIS OF TOFACITINIB FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS IN GREECE
    Vellopoulou, K.
    Stefanou, G.
    Tzanetakos, C.
    Boubouchairopoulou, N.
    Nakou, M.
    Kourlaba, G.
    VALUE IN HEALTH, 2019, 22 : S619 - S620
  • [3] COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS IN COLOMBIA
    Hansen, Tawnya
    Mak, Joyce
    Underwood, Fox
    Windsor, Joseph
    King, James
    Quan, Joshua
    Buie, Michael
    Coward, Stephanie
    Frolkis, Alex
    Leung, Alexander
    Ma, Christopher
    Novak, Kerri
    Panaccione, Remo
    Qian, Yiming
    Burisch, Johan
    Gearry, Richard
    Ng, Siew
    Kaplan, Gilaad
    INFLAMMATORY BOWEL DISEASES, 2022, 28 : S44 - S44
  • [4] Cost-effectiveness of tofacitinib for the treatment of moderate to severe active ulcerative colitis in Greece
    Vellopoulou, Katerina
    Stefanou, Garyfallia
    Tzanetakos, Charalampos
    Boubouchairopoulou, Nantia
    Nakou, Magdalini
    Gourzoulidis, George
    Kourlaba, Georgia
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (03) : 325 - 333
  • [5] COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS IN COLOMBIA
    Gil, Fabio
    Julian-Banos, Fabian
    Amador, Luisa
    Castano, Natalia
    Reyes, Juan
    GASTROENTEROLOGY, 2022, 162 (03) : S44 - S44
  • [6] COST-EFFECTIVENESS ANALYSIS OF TRANSTHYRETIN-ASSOCIATED AMYLOID CARDIOMYOPATHY FROM THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE
    Sebastiao, M.
    Ferreira, P.
    Senna, T.
    Alexandre, R. F.
    Almeida, P.
    VALUE IN HEALTH, 2023, 26 (06) : S156 - S156
  • [7] COST-EFFECTIVENESS OF 5-ASA THERAPY IN COMBINATION WITH BIOLOGICS OR TOFACITINIB IN THE TREATMENT OF ULCERATIVE COLITIS
    Shaffer, Seth
    Huang, Elbert
    Patel, Shivani
    Rubin, David T.
    GASTROENTEROLOGY, 2020, 158 (06) : S659 - S660
  • [8] Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis
    Shaffer, Seth R.
    Huang, Elbert
    Patel, Shivani
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (01): : 125 - 133
  • [9] BUDGETARY IMPACT OF INFLIXIMAB BIOSIMILAR IN THE TREATMENT OF PSORIASIS AND ULCERATIVE COLITIS IN THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTHCARE SYSTEM
    Alexandre, R. F.
    Salgado De Santana, C. F.
    Senna, T.
    VALUE IN HEALTH, 2019, 22 : S49 - S50
  • [10] COST-EFFECTIVENESS ANALYSIS OF EMICIZUMAB VERSUS BYPASSING AGENTS IN PATIENTS WITH HEMOPHILIA A WITH INHIBITORS IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE
    Souza, P.
    Puopolo, G. R.
    Leme-Souza, R.
    VALUE IN HEALTH, 2019, 22 : S847 - S847
12345